After A -12.40% Drop In The Last Week, Does Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Still Make Sense To Buy?
During the last session, Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)’s traded shares were 1.08 million, with the beta value of the company hitting 1.80. At the end